ArticleCureus2025
When Cholangitis Reveals Liver Involvement in Hereditary Hemorrhagic Telangiectasia: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hereditary hemorrhagic telangiectasia (HHT) syndrome is a rare autosomal dominant hereditary disorder characterized by multiple arteriovenous malformations (AVMs), resulting from capillary dysplasia, responsible for arteriovenous shunting. It can affect various organs, including the lungs, liver, and central nervous system. Clinical manifestations are epistaxis, telangiectasias, and complications of visceral AVMs. Biliary involvement is uncommon and typically results from biliary ischemia. This can lead to complications such as cholangitis, biliary strictures, cysts, necrosis, and bilomas. Although less frequent, biliary complications may present similarly to bile duct obstruction or sepsis and necessitate careful management. We report the case of a 55-year-old patient with a history of unexplored epistaxis who presented with hepatic colic. Clinical and laboratory findings revealed telangiectasias, cholestasis, and an inflammatory syndrome. Imaging revealed hepatic artery dilatation, multiple AVMs in hepatic telangiectasias and a porto-hepatic shunt, and segmental cystic dilation of the bile ducts. The patient was treated for cholangitis and remains under surveillance. This case highlights the importance of multimodal imaging in evaluating hepatic involvement in patients with HHT. Indeed, a combination of ultrasound, multiphasic CT, and dynamic MRI helps reveal not only typical vascular abnormalities, including hepatic artery dilatation, telangiectasias, and arteriovenous shunts, but also biliary involvement. Regular follow-up is necessary to tailor management and prevent potential complications associated with this hereditary vascular syndrome.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.